ResMed CEO: Big Pharma is squarely focused on GLP-1 medications right now Image courtesy of ResMed ResMed CEO Mick Farrells stance on the issue is that the latest advances in both Big Tech and Big Pharma can potentially bring incredible numbers of new patients into the healthcare system where ResMed is uniquely positioned to provide ongoing care at home. Patients are voting with their wallets and respiratory therapists and physicians are voting with their recommendations and their prescriptions. During the companys first-quarter earnings call, Farrell said the company is laser-focused on growing the market to help people get on the therapy they need and on a pathway to better sleep, better health, and better long-term care
4-HNE, 4-Hydroxynonenal
Behzad, H., Sharma, A., Mousavizadeh, R., Lu, A
By taking L-Carnitine in liquid form, you can experience quicker results, improved endurance, and faster recovery
In ELIXA, the beneficial role of lixisenatide on UACR progression was evident only following statistical adjustments for predisposing factors in patients with baseline MA [12]
Working together, these components play a vital role in protecting your cells from oxidative damage while also supporting liver detoxification and maintaining a strong immune system